• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Microalbuminuria: Undervalued As A Risk Assessment Tool

  • — 18 Jun, 2009
Microalbuminuria: Undervalued As A Risk Assessment Tool
Hermann Haller
AudioMedica News
AudioMedica News
Microalbuminuria: Undervalued As A Risk Assessment Tool
Microalbuminuria: Undervalued As A Risk Assessment Tool
00:00 /
RSS Feed
Share
Link
Embed
Hermann Haller

Hermann Haller

Hermann Haller tells Peter Goodwin about the significant health risks—including for renal disease, myocardial infarction and stroke—which are going undetected across Europe because doctors are not testing their patients who have hypertension for microalbuminuria. He discusses the findings of a European Society of Hypertension survey revealing widespread ignorance among general practitioners, cardiologists and diabetologists.



LISTEN

[audio:https://www.audiomedica.com/podcasting/cardio/090615HermannHallerPODCAST.mp3]

You may also like...

  • Thrombolysis Before Primary PCI Increases Mortality Thrombolysis Before Primary PCI Increases Mortality 12 Sep, 2005
  • Audio Journal of Cardiovascular Medicine: September 4th 2006 Audio Journal of Cardiovascular Medicine: September 4th 2006 4 Sep, 2006
  • The Wingspan Stent: Safe Intra-Cranial Angioplasty? The Wingspan Stent: Safe Intra-Cranial Angioplasty? 9 Feb, 2007
  • Audio Journal of Cardiovascular Medicine: September 6th 2006 Audio Journal of Cardiovascular Medicine: September 6th 2006 6 Sep, 2006
  • Previous story Hydrochlorothiazide: Not Recommended For First-Line Therapy In Hypertension
  • Next story Czech Republic Sees Massive Decline In Cardiovascular Deaths With Hypertension Treatment And Awareness
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After Allogeneic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
    • New Front Line Standard for Older Patients with Chronic…
  • Home
  • Cardiovascular
  • Microalbuminuria: Undervalued As A Risk Assessment Tool

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.